"Standard of Care" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The minimum acceptable patient care, based on statutes, court decisions, policies, or professional guidelines.
| Descriptor ID |
D059039
|
| MeSH Number(s) |
N04.761.789.900 N05.715.840
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Standard of Care".
Below are MeSH descriptors whose meaning is more specific than "Standard of Care".
This graph shows the total number of publications written about "Standard of Care" by people in this website by year, and whether "Standard of Care" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 1 | 1 | 2 |
| 2013 | 1 | 0 | 1 |
| 2014 | 0 | 2 | 2 |
| 2015 | 1 | 1 | 2 |
| 2016 | 3 | 2 | 5 |
| 2017 | 3 | 3 | 6 |
| 2018 | 2 | 8 | 10 |
| 2019 | 1 | 5 | 6 |
| 2020 | 1 | 3 | 4 |
| 2021 | 0 | 1 | 1 |
| 2022 | 0 | 19 | 19 |
| 2023 | 2 | 23 | 25 |
| 2024 | 0 | 21 | 21 |
| 2025 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Standard of Care" by people in Profiles.
-
The Safety of Pulsed Electric Field Ablation Before Standard of Care Treatment for Patients With Metastatic Cancer. J Bronchology Interv Pulmonol. 2025 Oct 01; 32(4).
-
Hematopoietic cell transplant compared with standard care in adolescents and young adults with sickle cell disease. Blood Adv. 2025 Mar 11; 9(5):955-965.
-
Efficacy and Safety of Subcutaneous Abatacept Plus Standard Treatment for Active Idiopathic Inflammatory Myopathy: Phase 3 Randomized Controlled Trial. Arthritis Rheumatol. 2025 Jun; 77(6):765-776.
-
Adding Metastasis-Directed Therapy to Standard-of-Care Systemic Therapy for Oligometastatic Breast Cancer (EXTEND): A Multicenter, Randomized Phase 2 Trial. Int J Radiat Oncol Biol Phys. 2025 Mar 15; 121(4):885-893.
-
Janus kinase inhibitor monotherapy and combination therapies for myelofibrosis: what's the current standard of care? Expert Rev Hematol. 2024 Nov; 17(11):769-780.
-
A randomized non-inferiority study comparing imipenem/cilastatin/relebactam with standard-of-care Gram-negative coverage in cancer patients with febrile neutropenia. J Antimicrob Chemother. 2024 Oct 01; 79(10):2543-2553.
-
Is luspatercept the new standard of care in transfusion-dependent low-risk myelodysplastic syndromes? Clin Adv Hematol Oncol. 2024 Oct; 22(8):367-369.
-
Financial Improvements From Short Course Adjuvant Vaginal Cuff Brachytherapy in Early Endometrial Cancer Compared With Standard of Care, "SAVE" Trial. Pract Radiat Oncol. 2024 Nov-Dec; 14(6):e500-e506.
-
Hypofractionated Preoperative Radiation Should Not Yet Be Used as Standard of Care for Extremity and Truncal Soft Tissue Sarcoma. J Clin Oncol. 2024 Dec 20; 42(36):4240-4245.
-
Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium. J Clin Oncol. 2024 Oct 20; 42(30):3581-3592.